Release Date: 26/02/15 19:21 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 594.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%